Gameto Launches First U.S. Clinical Site for Patient Enrollment in Fertilo Study
Gameto Launches First U.S. Clinical Site for Patient Enrollment in Fertilo Study Gameto, a clinical-stage biotechnology company at the forefront of developing cutting-edge iPSC (induced pluripotent stem cell)-based therapies to…
Coya Therapeutics Reports Positive Interim Results of IL-2 and CTLA4-Ig Combination in Mild to Moderate Frontotemporal Dementia
Coya Therapeutics Reports Positive Interim Results of IL-2 and CTLA4-Ig Combination in Mild to Moderate Frontotemporal Dementia Coya Therapeutics, Inc. , a clinical-stage biotechnology company specializing in the development of…
FDA Approves Second Manufacturing Facility for ADSTILADRIN (nadofaragene firadenovec-vncg)
FDA Approves Second Manufacturing Facility for ADSTILADRIN (nadofaragene firadenovec-vncg) In a significant development for the biopharmaceutical industry, Ferring Pharmaceuticals has received approval from the U.S. Food and Drug Administration (FDA)…
CytoAgents Completes Cohort 1 Dose-Escalation in Phase 1B Clinical Trial for Cytokine Release Syndrome Research
CytoAgents Completes Cohort 1 Dose-Escalation in Phase 1B Clinical Trial for Cytokine Release Syndrome Research CytoAgents Inc., a clinical-stage biotechnology company at the forefront of developing therapies for immune-mediated disorders,…
Lumicera and Costco Partner to Offer Cost-Plus Specialty Pharmacy with Enhanced Pricing and Patient Support
Lumicera and Costco Partner to Offer Cost-Plus Specialty Pharmacy with Enhanced Pricing and Patient Support In a move poised to shake up the specialty pharmacy market, Lumicera Health Services, a…
Debiopharm and Oncodesign Services Partner to Advance Radiopharmaceuticals in Preclinical Research
Debiopharm and Oncodesign Services Partner to Advance Radiopharmaceuticals in Preclinical Research Debiopharm Research & Manufacturing S.A. (Debiopharm), a privately held, Swiss-based global biopharmaceutical company committed to advancing the treatment landscape…
Ray Therapeutics Gets $8M Grant to Work on New Gene Therapy for Vision Loss Disease
Ray Therapeutics Gets $8M Grant to Work on New Gene Therapy for Vision Loss Disease In a significant milestone for the field of regenerative medicine and vision restoration, Ray Therapeutics—a…
Gilead Sciences Reports Financial Results for First Quarter 2025
Gilead Sciences Reports Financial Results for First Quarter 2025 Gilead Sciences, Inc. (Nasdaq: GILD) has unveiled its financial and operational performance for the first quarter of 2025, underscoring a steady…
Creyon Bio Names Industry Veteran Serge Messerlian as CEO to Drive Growth and Partnerships
Creyon Bio Names Industry Veteran Serge Messerlian as CEO to Drive Growth and Partnerships Creyon Bio, a biotechnology company pioneering the use of artificial intelligence in oligonucleotide therapy development, has…
Novocure’s Optune Lua Earns CE Mark Approval for Treating Metastatic Non-Small Cell Lung Cancer
Novocure’s Optune Lua® Earns CE Mark Approval for Treating Metastatic Non-Small Cell Lung Cancer In a significant development for the treatment of advanced lung cancer, Novocure announced that its innovative…
Novocure to Present Late-Breaking Phase 3 PANOVA-3 Data for TTFields in Pancreatic Cancer at ASCO 2025
Novocure to Present Late-Breaking Phase 3 PANOVA-3 Data for TTFields in Pancreatic Cancer at ASCO 2025 Novocure, a global leader in innovative cancer treatments, has announced that it will present…
Zai Lab to Present Phase 1 Data on DLL3-Targeted ADC ZL-1310 at ASCO 2025
Zai Lab to Present Phase 1 Data on DLL3-Targeted ADC ZL-1310 at ASCO 2025 Zai Lab Limited , a leading innovative biopharmaceutical company, announced today that it will present updated…